0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.56%
Revenue growth above 1.5x 3606.HK's 4.46%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
9.40%
Gross profit growth above 1.5x 3606.HK's 5.60%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
21.32%
EBIT growth above 1.5x 3606.HK's 9.55%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
21.32%
Operating income growth above 1.5x 3606.HK's 12.78%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
66.19%
Net income growth above 1.5x 3606.HK's 9.80%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
67.59%
EPS growth above 1.5x 3606.HK's 10.34%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
67.59%
Diluted EPS growth above 1.5x 3606.HK's 10.34%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.74%
Share reduction while 3606.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.67%
Reduced diluted shares while 3606.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-166.08%
Negative OCF growth while 3606.HK is at 292.99%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-816.18%
Negative FCF growth while 3606.HK is at 162.64%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
47933.84%
10Y revenue/share CAGR above 1.5x 3606.HK's 340.34%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1.19%
5Y revenue/share CAGR under 50% of 3606.HK's 56.57%. Michael Burry would suspect a significant competitive gap or product weakness.
9.55%
3Y revenue/share CAGR under 50% of 3606.HK's 25.97%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-4802.15%
Negative 10Y OCF/share CAGR while 3606.HK stands at 471.82%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-181.71%
Negative 5Y OCF/share CAGR while 3606.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-137.36%
Negative 3Y OCF/share CAGR while 3606.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
387.58%
Net income/share CAGR at 75-90% of 3606.HK's 442.50%. Bill Ackman would press for strategic moves to boost long-term earnings.
-73.88%
Negative 5Y net income/share CAGR while 3606.HK is 37.31%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-43.89%
Negative 3Y CAGR while 3606.HK is 61.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
152.38%
5Y equity/share CAGR at 75-90% of 3606.HK's 203.00%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
54.75%
Below 50% of 3606.HK's 138.74%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-87.59%
Negative 5Y dividend/share CAGR while 3606.HK stands at 347.06%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
141.46%
Below 50% of 3606.HK's 2182.71%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
24.83%
Our AR growth while 3606.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-12.51%
Inventory is declining while 3606.HK stands at 0.10%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
21.68%
Positive asset growth while 3606.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.64%
Under 50% of 3606.HK's 10.98%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
281.70%
We have some new debt while 3606.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
75.26%
R&D growth of 75.26% while 3606.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
7.69%
We expand SG&A while 3606.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.